GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tianjin Pharmaceutical Da Ren Tang Group Corp 600329.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

41.77

-0.83%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCN¥4.93bnCN¥5.35bnCN¥5.71bn
Revenue, highestCN¥4.93bnCN¥5.35bnCN¥5.71bn
Revenue, lowestCN¥4.93bnCN¥5.35bnCN¥5.71bn
Earnings per share1.341.541.71
Earnings per share, highest1.341.541.71
Earnings per share, lowest1.341.541.71
Analysts111

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth -3.6% a year over 10 years. Return on equity 30.0%.

Model fair value

27.00

From earnings 27.00, from revenue 32.42.

Piotroski score

4 / 9

A nine-point test of financial strength, for 31 Dec 2024.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.